- Info
- Insider Trading
- Financials
- Holders: TIL, TIL
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL)
CUSIP: 45783C101
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, $0.000001 par value per share
- Shares outstanding
- 6,795,789
- Total 13F shares
- 79,945,385
- Share change
- +1,899,557
- Total reported value
- $859,413,492
- Price per share
- $10.75
- Number of holders
- 74
- Value change
- +$16,751,395
- Number of buys
- 34
- Number of sells
- 27
Quarterly Holders Quick Answers
What is CUSIP 45783C101?
CUSIP 45783C101 identifies TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45783C101:
Top shareholders of TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
219%
|
14,895,240
|
$254,857,000 | — | 31 Dec 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
184%
|
12,486,787
|
$213,649,000 | — | 31 Dec 2021 | |
| CPMG Inc |
13F
|
Company |
125%
|
8,478,790
|
$145,072,000 | — | 31 Dec 2021 | |
| VR Adviser, LLC |
13F
|
Company |
101%
|
6,865,076
|
$117,461,000 | — | 31 Dec 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
72%
|
4,870,793
|
$83,339,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
61%
|
4,113,443
|
$70,381,000 | — | 31 Dec 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
57%
|
3,893,700
|
$66,621,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
49%
|
3,321,941
|
$56,838,000 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
45%
|
3,057,792
|
$52,319,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
39%
|
2,656,634
|
$45,455,000 | — | 31 Dec 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
35%
|
2,385,457
|
$40,815,000 | — | 31 Dec 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
29%
|
1,991,950
|
$34,082,000 | — | 31 Dec 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
20%
|
1,392,415
|
$23,824,000 | — | 31 Dec 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
19%
|
1,289,899
|
$22,070,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
11%
|
761,572
|
$13,030,000 | — | 31 Dec 2021 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
10%
|
713,221
|
$12,203,000 | — | 31 Dec 2021 | |
| Fairmount Funds Management LLC |
13F
|
Company |
9.9%
|
673,905
|
$11,531,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
9.6%
|
652,721
|
$11,168,000 | — | 31 Dec 2021 | |
| Artal Group S.A. |
13F
|
Company |
6.6%
|
450,000
|
$7,700,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
6.1%
|
412,708
|
$7,062,000 | — | 31 Dec 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
6%
|
408,140
|
$6,983,000 | — | 31 Dec 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
3.3%
|
226,881
|
$3,881,935 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
3.3%
|
225,061
|
$3,851,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
3.2%
|
218,515
|
$3,645,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
3%
|
201,207
|
$3,443,000 | — | 31 Dec 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
2.2%
|
149,202
|
$2,553,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.8%
|
123,420
|
$2,112,000 | — | 31 Dec 2021 | |
| QVT Financial LP |
13F
|
Company |
1.5%
|
98,644
|
$1,688,000 | — | 31 Dec 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
1.3%
|
86,005
|
$1,472,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
81,772
|
$1,399,000 | — | 31 Dec 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
1.1%
|
71,400
|
$1,222,000 | — | 31 Dec 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.86%
|
58,779
|
$1,006,000 | — | 31 Dec 2021 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.85%
|
57,719
|
$988,000 | — | 31 Dec 2021 | |
| HighVista Strategies LLC |
13F
|
Company |
0.84%
|
56,901
|
$974,000 | — | 31 Dec 2021 | |
| Parametrica Management Ltd |
13F
|
Company |
0.75%
|
50,699
|
$867,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.65%
|
44,257
|
$757,000 | — | 31 Dec 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.56%
|
38,032
|
$651,000 | — | 31 Dec 2021 | |
| Curative Ventures V LLC |
13F
|
Company |
559%
|
37,980,073
|
$649,839 | — | 31 Dec 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.5%
|
33,725
|
$577,000 | — | 31 Dec 2021 | |
| ProShare Advisors LLC |
13F
|
Company |
0.44%
|
29,983
|
$514,000 | — | 31 Dec 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.43%
|
29,457
|
$504,000 | — | 31 Dec 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.42%
|
28,735
|
$492,000 | — | 31 Dec 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.4%
|
27,324
|
$468,000 | — | 31 Dec 2021 | |
| Rock Creek Group, LP |
13F
|
Company |
0.51%
|
34,795
|
$404,000 | — | 31 Dec 2021 | |
| CNA FINANCIAL CORP |
13F
|
Company |
0.33%
|
22,688
|
$388,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
22,553
|
$386,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.33%
|
22,249
|
$381,000 | — | 31 Dec 2021 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.32%
|
22,000
|
$376,000 | — | 31 Dec 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.31%
|
21,095
|
$361,000 | — | 31 Dec 2021 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.3%
|
20,414
|
$349,284 | — | 31 Dec 2021 |
Institutional Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) as of Q1 2022
As of 31 Mar 2022,
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,945,385 shares.
The largest 10 holders included
FMR LLC, Vivo Capital, LLC, CPMG Inc, VR Adviser, LLC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, BlackRock Inc., ALLIANCEBERNSTEIN L.P., and HHLR ADVISORS, LTD..
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
74
Q1 2022 holders
74
Holder diff
0
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.